FGFR2 rearrangements/mutations occur in 12–17% of intrahepatic cholangiocarcinoma, resulting in increased cell proliferation, tumor growth and metastatization [25]. The gene discussed is FGFR2; the disease is intrahepatic cholangiocarcinoma.